Back To Search Instructions
Protocols
2 protocol(s) meet the specified criteria
PI: Dittus, Christopher
Protocol No.TitleStatus
GO29383A Phase Ib Study of the Safety and Pharmacology of Atezolizumab Administered with Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma or Atezolizumab Administered with Obinutuzumab or Tazemetostat in Patients with Relapsed/Refractory Diffuse Large B-Cell LymphomaOpen
SGN19A-003A randomized, open-label phase 2 study of denintuzumab mafodotin (SGN-CD19A) plus rituximab, ifosfamide, carboplatin, and etoposide (19A+RICE) chemotherapy vs. RICE in the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are candidates for autologous stem cell transplantOpen